Allgens(SH:688613)2023-04-20 16:00Financial Performance - The company's operating revenue for Q1 2023 was CNY 47,808,816.25, representing a year-on-year increase of 4.18%[5] - The net profit attributable to shareholders for the same period was CNY 18,513,101.38, reflecting a significant increase of 40.8% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 14,999,368.24, which is an increase of 113.97% year-on-year[5] - Basic and diluted earnings per share were both CNY 0.14, marking a 40% increase year-on-year[6] - Net profit for Q1 2023 was ¥16,771,370.97, up from ¥11,205,537.61 in Q1 2022, indicating a growth of approximately 49.5%[21] - Total profit for Q1 2023 was ¥19,202,945.18, compared to ¥14,770,724.63 in Q1 2022, representing an increase of about 30.9%[21] Cash Flow - The net cash flow from operating activities was CNY 12,458,006.69, up by 41.03% compared to the same period last year[6] - Cash flow from operating activities for Q1 2023 was ¥12,458,006.69, compared to ¥8,833,565.49 in Q1 2022, marking an increase of approximately 41.5%[26] - The company reported a cash outflow from investment activities of ¥61,407,471.15 in Q1 2023, compared to ¥69,017,315.53 in Q1 2022, a decrease of approximately 11%[26] - Cash outflow from financing activities was ¥6,193,364.62 in Q1 2023, up from ¥3,586,013.00 in Q1 2022, indicating an increase of about 72%[26] - The net increase in cash and cash equivalents for Q1 2023 was -$55,142,829.08, compared to -$47,739,142.15 in the previous year[27] - The beginning cash and cash equivalents balance was $259,872,075.74, down from $411,306,320.84 year-over-year[27] - The ending cash and cash equivalents balance stood at $204,729,246.66, a decrease from $363,567,178.69 compared to the same period last year[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,473,923,957.00, a slight increase of 1.01% from the end of the previous year[6] - As of March 31, 2023, the total assets of the company amounted to ¥1,473,923,957, an increase from ¥1,459,216,334.75 as of December 31, 2022, reflecting a growth of approximately 1.6%[16] - The company's total liabilities decreased to ¥131,435,469.02 from ¥133,499,217.74, indicating a reduction of about 1.5%[18] - The total current assets reached ¥1,156,340,201.07, slightly up from ¥1,142,346,268.10, indicating a growth of approximately 1.2%[16] - The non-current assets totaled ¥317,583,755.93, a marginal increase from ¥316,870,066.65, showing a growth of about 0.2%[17] - The company's retained earnings grew to ¥257,761,513.66 from ¥239,248,412.28, reflecting an increase of about 7.7%[18] - The total equity of the company increased to ¥1,342,488,487.98 from ¥1,325,717,117.01, reflecting a growth of about 1.3%[18] Expenses - Research and development expenses totaled CNY 5,978,004.80, a decrease of 67.49% compared to the same period last year[6] - The proportion of R&D expenses to operating revenue was 12.5%, down by 27.56 percentage points year-on-year[6] - Research and development expenses for Q1 2023 were ¥5,978,004.80, down from ¥18,387,296.71 in Q1 2022, a decrease of about 67.5%[21] - Sales expenses surged to ¥10,227,144.80 in Q1 2023 from ¥3,438,766.32 in Q1 2022, an increase of approximately 197.5%[20] Shareholder Information - The company reported a total of 11,684 common shareholders at the end of the reporting period[13]